Literature DB >> 21957294

Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences.

Peter Reuther1, Benjamin Mänz, Linda Brunotte, Martin Schwemmle, Kerstin Wunderlich.   

Abstract

Assembly of the heterotrimeric influenza virus polymerase complex from the individual subunits PB1, PA, and PB2 is a prerequisite for viral replication. The conserved protein-protein interaction sites have been suggested as potential drug targets. To characterize the PB1-PB2 interface, we fused the PB1-binding domain of PB2 to green fluorescent protein (PB2(1-37)-GFP) and determined its competitive inhibitory effect on the polymerase activity of influenza A virus strains. Coexpression of PB2(1-37)-GFP in a polymerase reconstitution system led to substantial inhibition of the polymerase of A/WSN/33 (H1N1). Surprisingly, polymerases of other strains, including A/SC35M (H7N7), A/Puerto Rico/8/34 (H1N1), A/Hamburg/4/2009 (H1N1), and A/Thailand/1(KAN-1)/2004 (H5N1), showed various degrees of resistance. Individual exchange of polymerase subunits and the nucleoprotein between the sensitive WSN polymerase and the insensitive SC35M polymerase mapped the resistance to both PB1 and PA of SC35M polymerase. While PB2(1-37)-GFP bound equally well to the PB1 subunits of both virus strains, PB1-PA dimers of SC35M polymerase showed impaired binding compared to PB1-PA dimers of WSN polymerase. The use of PA(SC35M/WSN) chimeras revealed that the reduced affinity of the SC35M PB1-PA dimer was mediated by the N-terminal 277 amino acids of PA. Based on these observations, we speculate that the PB1-PA dimer formation of resistant polymerases shields the PB2(1-37) binding site, whereas sensitive polymerases allow this interaction, suggesting different assembly strategies of the trimeric polymerase complex between different influenza A virus strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21957294      PMCID: PMC3233147          DOI: 10.1128/JVI.00868-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Functional domains of the influenza A virus PB2 protein: identification of NP- and PB1-binding sites.

Authors:  Emma Poole; Debra Elton; Liz Medcalf; Paul Digard
Journal:  Virology       Date:  2004-03-30       Impact factor: 3.616

2.  Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases.

Authors:  R Müller; O Poch; M Delarue; D H Bishop; M Bouloy
Journal:  J Gen Virol       Date:  1994-06       Impact factor: 3.891

3.  Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure.

Authors:  S González; T Zürcher; J Ortín
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

4.  A 48-amino-acid region of influenza A virus PB1 protein is sufficient for complex formation with PA.

Authors:  D R Pérez; R O Donis
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Mutational analysis identifies functional domains in the influenza A virus PB2 polymerase subunit.

Authors:  B Perales; S de la Luna; I Palacios; J Ortín
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  The PA subunit is required for efficient nuclear accumulation of the PB1 subunit of the influenza A virus RNA polymerase complex.

Authors:  Ervin Fodor; Matt Smith
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Complex formation between influenza virus polymerase proteins expressed in Xenopus oocytes.

Authors:  P Digard; V C Blok; S C Inglis
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

8.  Influenza virus polymerase basic protein 1 interacts with influenza virus polymerase basic protein 2 at multiple sites.

Authors:  S K Biswas; D P Nayak
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  In vitro assembly of PB2 with a PB1-PA dimer supports a new model of assembly of influenza A virus polymerase subunits into a functional trimeric complex.

Authors:  Tao Deng; Jane Sharps; Ervin Fodor; George G Brownlee
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

10.  Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.

Authors:  O Poch; I Sauvaget; M Delarue; N Tordo
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  11 in total

1.  Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells.

Authors:  Benjamin Mänz; Linda Brunotte; Peter Reuther; Martin Schwemmle
Journal:  Nat Commun       Date:  2012-05-01       Impact factor: 14.919

2.  Discovery of anti-influenza nucleoside triphosphates targeting the catalytic site of A/PR/8/34/H1N1 polymerase.

Authors:  Nataraj Sekhar Pagadala; Rakesh Bhat; Jagadeesh Kumar D; Abdolamir Landi
Journal:  Med Chem Res       Date:  2020-05-24       Impact factor: 1.965

3.  Eurasian Avian-Like Swine Influenza A Viruses Escape Human MxA Restriction through Distinct Mutations in Their Nucleoprotein

Authors:  Dominik Dornfeld; Philipp P Petric; Ebrahim Hassan; Roland Zell; Martin Schwemmle
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

4.  Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.

Authors:  Giulia Muratore; Laura Goracci; Beatrice Mercorelli; Ágnes Foeglein; Paul Digard; Gabriele Cruciani; Giorgio Palù; Arianna Loregian
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

5.  TRIM32 Senses and Restricts Influenza A Virus by Ubiquitination of PB1 Polymerase.

Authors:  Bishi Fu; Lingyan Wang; Hao Ding; Jens C Schwamborn; Shitao Li; Martin E Dorf
Journal:  PLoS Pathog       Date:  2015-06-09       Impact factor: 6.823

6.  The N-terminal fragment of a PB2 subunit from the influenza A virus (A/Hong Kong/156/1997 H5N1) effectively inhibits RNP activity and viral replication.

Authors:  Takahito Kashiwagi; Koyu Hara; Yoko Nakazono; Yusaku Uemura; Yoshihiro Imamura; Nobuyuki Hamada; Hiroshi Watanabe
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

Review 7.  The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design.

Authors:  Annelies Stevaert; Lieve Naesens
Journal:  Med Res Rev       Date:  2016-08-29       Impact factor: 12.944

8.  Comparative influenza protein interactomes identify the role of plakophilin 2 in virus restriction.

Authors:  Lingyan Wang; Bishi Fu; Wenjun Li; Girish Patil; Lin Liu; Martin E Dorf; Shitao Li
Journal:  Nat Commun       Date:  2017-02-07       Impact factor: 14.919

9.  Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.

Authors:  Shuofeng Yuan; Hin Chu; Jiahui Ye; Kailash Singh; Ziwei Ye; Hanjun Zhao; Richard Y T Kao; Billy K C Chow; Jie Zhou; Bo-Jian Zheng
Journal:  Antiviral Res       Date:  2016-11-10       Impact factor: 5.970

10.  Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein.

Authors:  Benjamin Mänz; Dominik Dornfeld; Veronika Götz; Roland Zell; Petra Zimmermann; Otto Haller; Georg Kochs; Martin Schwemmle
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.